Cargando…
The circadian clock gene Bmal1 facilitates cisplatin-induced renal injury and hepatization
Cisplatin is one of the most potent chemotherapy drugs to treat cancers, but its clinical application remains limited due to severe nephrotoxicity. Several approaches have been developed to minimize such side effects, notably including chronotherapy, a well-known strategy based on the circadian cloc...
Autores principales: | Zha, Min, Tian, Ting, Xu, Weilong, Liu, Su, Jia, Jia, Wang, Lijuan, Yan, Qianhua, Li, Nan, Yu, Jiangyi, Huang, Liji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287064/ https://www.ncbi.nlm.nih.gov/pubmed/32522976 http://dx.doi.org/10.1038/s41419-020-2655-1 |
Ejemplares similares
-
Regulation of circadian clock transcriptional output by CLOCK:BMAL1
por: Trott, Alexandra J., et al.
Publicado: (2018) -
BMAL1 dephosphorylation determines the pace of the circadian clock
por: Schibler, Ueli
Publicado: (2021) -
Interaction of circadian clock proteins PER2 and CRY with BMAL1 and CLOCK
por: Langmesser, Sonja, et al.
Publicado: (2008) -
Insulin post-transcriptionally modulates Bmal1 protein to affect the hepatic circadian clock
por: Dang, Fabin, et al.
Publicado: (2016) -
Opposite Carcinogenic Effects of Circadian Clock Gene BMAL1
por: Korkmaz, Tuba, et al.
Publicado: (2018)